These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20837598)

  • 1. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
    Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
    Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
    Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
    Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
    Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
    Guo Y; Li B; Xu X; Wu R; Li W
    Cell Physiol Biochem; 2015; 37(4):1345-54. PubMed ID: 26488172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.
    Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ
    Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
    Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH
    Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
    Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
    Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
    Wang M; Hao FY; Wang JG; Xiao W
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group IIa sPLA2 inhibition attenuates NF-κB activity and promotes apoptosis of lung cancer cells.
    Yu JA; Kalatardi S; Dohse J; Sadaria MR; Meng X; Fullerton DA; Weyant MJ
    Anticancer Res; 2012 Sep; 32(9):3601-7. PubMed ID: 22993297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer.
    Koumakpayi IH; Le Page C; Mes-Masson AM; Saad F
    Br J Cancer; 2010 Mar; 102(7):1163-73. PubMed ID: 20216540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
    Kuwata H; Nonaka T; Murakami M; Kudo I
    J Biol Chem; 2005 Jul; 280(27):25830-9. PubMed ID: 15878884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
    Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
    Beck S; Lambeau G; Scholz-Pedretti K; Gelb MH; Janssen MJ; Edwards SH; Wilton DC; Pfeilschifter J; Kaszkin M
    J Biol Chem; 2003 Aug; 278(32):29799-812. PubMed ID: 12782627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
    Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
    Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
    Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.